Published in N Z Med J on May 10, 2002
Cancer flourishes. N Z Med J (2002) 1.40
Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10. PLoS One (2016) 0.75
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst (2002) 3.46
Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst (2003) 2.84
Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol (2005) 2.70
A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer (2006) 2.35
Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.14
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev (2006) 1.35
Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev (2002) 1.30
Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study. Cancer Res (2010) 1.26
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev (2002) 1.21
Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol (2004) 1.20
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Is there a positive association between mammographic density and bone mineral density? Breast Cancer Res (2006) 1.17
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev (2005) 1.16
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics (2002) 1.10
ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J Natl Cancer Inst (2003) 1.10
Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol (2007) 1.10
Foods, nutrients and prostate cancer. Cancer Causes Control (2004) 1.09
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev (2006) 1.07
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer. Genet Epidemiol (2003) 1.05
Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Is there overlap between the genetic determinants of mammographic density and bone mineral density? Cancer Epidemiol Biomarkers Prev (2005) 1.01
Early growth, adult body size and prostate cancer risk. Int J Cancer (2003) 0.99
The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev (2002) 0.94
Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiol Biomarkers Prev (2004) 0.94
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrology (Carlton) (2007) 0.93
Predictors of mammographic density: insights gained from a novel regression analysis of a twin study. Cancer Epidemiol Biomarkers Prev (2008) 0.92
Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol (2006) 0.90
An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol (2009) 0.89
The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Cancer Epidemiol Biomarkers Prev (2003) 0.88
Is MSH2 a breast cancer susceptibility gene? Fam Cancer (2007) 0.87
A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 0.87
The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians. Nephrol Dial Transplant (2004) 0.87
Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women. Lancet (2002) 0.87
Chromosome 14q LOH in localized clear cell renal cell carcinoma. J Pathol (2002) 0.86
Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians. Nephrology (Carlton) (2004) 0.85
Increased incidence of squamous cell carcinoma of eye after kidney transplantation. J Natl Cancer Inst (2007) 0.84
No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res (2002) 0.83
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer. Hum Mutat (2005) 0.81
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res (2005) 0.79
The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002. Am J Kidney Dis (2006) 0.79
Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer? Breast Cancer Res Treat (2007) 0.79
Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia. Nephrology (Carlton) (2004) 0.77
The evolution of collagen expression in sarcomatoid renal cell carcinoma. Hum Pathol (2007) 0.75